Suppr超能文献

摄入富含二十碳五烯酸和二十二碳六烯酸的鱼油(其含量可通过饮食获取)可降低收缩期高血压成年人的血压:一项回顾性分析。

Consumption of Fish Oil Providing Amounts of Eicosapentaenoic Acid and Docosahexaenoic Acid That Can Be Obtained from the Diet Reduces Blood Pressure in Adults with Systolic Hypertension: A Retrospective Analysis.

作者信息

Minihane Anne M, Armah Christopher K, Miles Elizabeth A, Madden Jacqueline M, Clark Allan B, Caslake Muriel J, Packard Chris J, Kofler Bettina M, Lietz Georg, Curtis Peter J, Mathers John C, Williams Christine M, Calder Philip C

机构信息

Norwich Medical School, University of East Anglia, Norwich, United Kingdom;

Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Reading, United Kingdom;

出版信息

J Nutr. 2016 Mar;146(3):516-23. doi: 10.3945/jn.115.220475. Epub 2016 Jan 27.

Abstract

BACKGROUND

Although many randomized controlled trials (RCTs) have examined the effects of the n-3 (ω-3) fatty acids eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) on blood pressure (BP) and vascular function, the majority have used doses of EPA+DHA of >3 g/d, which are unlikely to be achieved by dietary manipulation.

OBJECTIVE

The objective was to examine, by using a retrospective analysis from a multicenter RCT, the impact of recommended EPA+DHA intakes achievable through diet on systolic and diastolic BPs and microvascular function in adults in the United Kingdom.

METHODS

In a double-blind, placebo-controlled RCT, healthy men and women (n = 312) consumed a control oil or fish oil (FO) providing 0.7 or 1.8 g EPA+DHA/d, in random order, each for 8 wk. Fasting BP and microvascular function (using laser Doppler iontophoresis) were assessed and plasma collected for the quantification of markers of vascular function. Participants were retrospectively genotyped for the endothelial nitric oxide synthase (eNOS) rs1799983 variant.

RESULTS

No effects of n-3 fatty acid treatment or any treatment × eNOS genotype interactions were evident in the group as a whole for any of the clinical or biochemical outcomes. Assessment of response according to hypertension status at baseline indicated a significant (P = 0.046) FO-induced reduction (mean: 5 mm Hg) in systolic BP, specifically in those with isolated systolic hypertension (n = 31). No dose response was observed.

CONCLUSIONS

These findings indicate that in adults with isolated systolic hypertension, daily doses of EPA+DHA as low as 0.7 g show clinically meaningful BP reductions, which, at a population level, could be associated with lower cardiovascular disease risk. Confirmation of findings in an RCT in which participants are prospectively recruited on the basis of BP status is required to draw definite conclusions.

摘要

背景

尽管许多随机对照试验(RCT)已研究了n-3(ω-3)脂肪酸二十碳五烯酸(EPA;20:5n-3)和二十二碳六烯酸(DHA;22:6n-3)对血压(BP)和血管功能的影响,但大多数试验使用的EPA+DHA剂量>3 g/d,通过饮食调整不太可能达到这一剂量。

目的

通过一项多中心RCT的回顾性分析,研究通过饮食可达到的推荐EPA+DHA摄入量对英国成年人收缩压和舒张压以及微血管功能的影响。

方法

在一项双盲、安慰剂对照的RCT中,312名健康男性和女性随机依次食用提供0.7或1.8 g EPA+DHA/d的对照油或鱼油(FO),每种持续8周。评估空腹血压和微血管功能(使用激光多普勒离子导入法),并采集血浆以定量血管功能标志物。对参与者进行内皮型一氧化氮合酶(eNOS)rs1799983变异的回顾性基因分型。

结果

对于任何临床或生化结果,在整个组中均未发现n-3脂肪酸治疗或任何治疗×eNOS基因型相互作用的影响。根据基线时的高血压状态评估反应表明,FO可使收缩压显著降低(平均:5 mmHg)(P = 0.046),特别是在单纯收缩期高血压患者(n = 31)中。未观察到剂量反应。

结论

这些发现表明,在单纯收缩期高血压成年人中,每日低至0.7 g的EPA+DHA剂量可使血压出现具有临床意义的降低,在人群水平上,这可能与较低的心血管疾病风险相关。需要在一项根据血压状态前瞻性招募参与者的RCT中对这些发现进行验证,以得出明确结论。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验